Vanaja Ragavan, M.D.
President and CEO
Dr. Ragavan is a board certified endocrinologist who has worked in the pharmaceutical industry for over 20 years, first as a Medical Officer at the FDA, then in large multinational pharmaceutical companies with increasing responsibilities. For the past six years, she has worked in the entrepreneurial area as an inventor, company founder, angel investor and in management roles. Dr. Ragavan is uniquely qualified to lead this company, having spent her entire career in developing drugs, devices, and now diagnostics, and has managed multi-disciplinary teams ranging from global companies to startup ventures. Dr. Ragavan founded Aviana Molecular Technologies in 2008 to fulfill unmet clinical need in diagnosis of infections and currently provides corporate, clinical, and marketing strategy. During the last two and a half years, Dr. Ragavan has located a home for the Company at the Lankenau Institute for Medical Research and has sustained and grown a vibrant and creative team that has advanced its products to an early prototype. Dr. Ragavan graduated with an A.B. from Harvard University and an M.D. from NYU Medical School.
Edward Peterson
Global General Manager
Mr. Peterson founded AcuFocus, an ophthalmic medical device company focused on developing an intracorneal inlay to increase the depth of focus in people with presbyopia. Serving as the company’s President and CEO for over a decade, Mr. Peterson was instrumental in helping AcuFocus raise over $133 million and growing the company from a promising start-up to a global commercial enterprise. Boasting over three decades of ophthalmic industry experience, Mr. Peterson began his career at industry icons CooperVision and Alcon. Prior to joining AcuFocus, he served as Vice President of Business Development for the Innovation Factory, an incubator company for new and emerging technologies. Mr. Peterson has developed significant international business relationships over the last decade. Currently, Mr. Peterson is Chairman of the Board of Directors for Visiometrics, as well as Chairman to Accelerated Vision Business Group. Mr. Peterson is also a member of AAO Corporate Advisory Council. A U.S. Marine Corps veteran, Mr. Peterson holds a B.A. in Marketing from the University of Iowa.
Soumen Das
Dr Soumen Das received his PhD in Biotechnology from Indian Institute of Technology, Kharagpur in 2010. He worked as research assistant professor in Advanced Materials Processing and Analysis Center and Nanoscience Technology Center, University of Central Florida, Orlando for three years. His research expertise is in nanotechnology (synthesis and characterization), surface chemistry (surface functionalization and bioconjugation), immunology, and cell biology. He has more than 50 international publications, 9 patent application sand several awards
Paul Sansone
CFO
Paul Sansone is a Partner for TechCXO, an on demand executive services firm based in Atlanta. Previously, Sansone was the Chief Financial Officer for The Boys & Girls Clubs of America, a $1.8B youth serving federation. Sansone was also CFO of Atlanta-based B Corporation Better World Books, a book and media e-commerce company with $70M in revenues, which has donated more than $20 million to literacy programs around the world. Sansone was also Vice-President of Finance for Cisco Systems and Scientific Atlanta, as well as a Finance Manager at IBM and a Senior Auditor at Price Waterhouse Coopers. Sansone has a BS in Accounting and a BS in Economics from St. Francis University of Pennsylvania and an MBA from Duke University’s Fuqua School of Business. Paul is also a Certified Public Accountant.
Aarti Chowla, MS
Senior Research Scientist
Aarti Chawla received her MS in Immunology and Microbiology in 2009 from University of Florida (Gainesville). She worked as a Product Development Scientist at Banyan Biomarkers, San Diego, CA for seven years. She played an integral role in the development of two IVD biomarker assays for the diagnosis of Traumatic Brain Injury (TBI). Her research expertise is in Immunoassay development (from early research to manufacturing), protein purification, molecular biology and microbiology. She also has experience in FDA studies and technical writing for regulatory submissions.